HEDIS® Results

Measure

2024 Rate

2025 Rate

Goal

Prevention and Screening

Adult Immunization Status (AIS-E) - Influenza (Total)

23.15

12.17

24.30

Adult Immunization Status (AIS-E) - Pneumococcal (66+)

66.67

12.50

52.50

Adult Immunization Status (AIS-E) - Td/Tdap (Total)

41.22

38.67

47.50

Breast Cancer Screening (BCS-E)

64.29

52.94

76.77

Cervical Cancer Screening (CCS)

55.41

49.64

65.03

Childhood Immunization Status (CIS) - Combo 10

35.29

0.00

46.88

Chlamydia Screening in Women (CHL) Total

65.00

33.02

56.04

Colorectal Cancer Screening (COL-E) -Total

35.44

42.59

60.80

Immunizations for Adolescents (IMA) - Combination 2

33.33

0.00

36.86

Immunizations for Adolescents (IMA) - HPV

33.33

0.00

32.70

Immunizations for Adolescents (IMA) - Meningococcal

88.89

87.50

80.90

Immunizations for Adolescents (IMA) - Tdap

88.89

87.50

86.40

Oral Evaluation, Dental Services (OED) - Total

NB

NB

24.19

Weight Assessment and Counseling for Nutrition and Physical Activity for Children/Adolescents (WCC) - BMI percentile (Total)

77.88

68.37

84.30

Weight Assessment and Counseling for Nutrition and Physical Activity for Children/Adolescents (WCC) - Counseling for Nutrition (Total)

68.27

58.64

77.20

Weight Assessment and Counseling for Nutrition and Physical Activity for Children/Adolescents (WCC) - Counseling for Physical Activity (Total)

63.46

55.96

74.80

Respiratory

Asthma Medication Ratio (AMR) -Total

100.00

83.33

84.65

Cardiovascular

Controlling High Blood Pressure (CBP)

61.05

35.90

73.97

Diabetes

Eye Exam for Patients With Diabetes (EED)

34.18

43.28

53.33

Glycemic Status Assessment for Patients With Diabetes (GSD) - Glycemic Status >9.0%

Note: this is an inverse measure, meaning a rate lower than the goal indicates better performance.

39.24

26.87

19.71

Kidney Health Evaluation for Patients With Diabetes (KED) - Total

38.46

56.28

58.43

Behavioral Health

Antidepressant Medication Management (AMM) - Effective Acute Phase Treatment

60.71

56.76

82.80

Antidepressant Medication Management (AMM) - Effective Continuation Phase Treatment

48.81

45.95

67.20

Follow-Up After Hospitalization for Mental Illness (FUH) - 30 days (Total)

80.00

66.67

71.80

Follow-Up After Hospitalization for Mental Illness (FUH) - 7 days (Total)

60.00

48.15

50.00

Depression Screening and Follow-Up for Adolescents and Adults (DSF-E) - Depression Screening (Total)

NR

17.66

9.30

Depression Screening and Follow-Up for Adolescents and Adults (DSF-E) - Follow-Up on Positive Screen (Total)

NR

88.00

84.90

Appropriateness of Use

Appropriate Treatment for Upper Respiratory Infection (URI) -Total

90.83

87.15

85.12

Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) - Total

62.22

54.17

54.88

Use of Imaging Studies for Low Back Pain (LBP) - Total

75.00

71.43

75.53

Access and Availability of Care

Initiation and Engagement of Substance Use Disorder Treatment (IET) - Initiation of SUD Treatment - Total (Total)

59.46

37.50

46.10

Initiation and Engagement of Substance Use Disorder Treatment (IET) - Engagement of SUD Treatment - Total (Total)

21.62

12.50

15.90

Prenatal and Postpartum Care (PPC) - Timeliness of Prenatal Care

75.93

77.08

89.51

Prenatal and Postpartum Care (PPC) - Postpartum Care

87.04

63.54

88.89

Utilization

Child and Adolescent Well-Care Visits (WCV) - Total

58.50

44.84

58.56

Well-Child Visits in the First 30 Months of Life (W30) - (First 15 Months)

50.00

87.50

85.20

Well-Child Visits in the First 30 Months of Life (W30) - (15 Months-30 Months)

69.23

66.67

90.50